Skip to main content
. 2021 Mar 1;188(1):237–248. doi: 10.1007/s10549-021-06152-4

Fig. 3.

Fig. 3

Rate of germline pathogenic/likely pathogenic variants or VUS per number of indications fulfilled from multigene panel test in Thai patients with breast cancer